16-2089126-A-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001009944.3(PKD1):​c.*601T>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.276 in 169,558 control chromosomes in the GnomAD database, including 9,495 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.29 ( 9233 hom., cov: 34)
Exomes 𝑓: 0.15 ( 262 hom. )

Consequence

PKD1
NM_001009944.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.0540

Publications

19 publications found
Variant links:
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC2 Gene-Disease associations (from GenCC):
  • tuberous sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • tuberous sclerosis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
  • lymphangioleiomyomatosis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • tuberous sclerosis complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 16-2089126-A-T is Benign according to our data. Variant chr16-2089126-A-T is described in ClinVar as [Benign]. Clinvar id is 3780389.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.581 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PKD1NM_001009944.3 linkc.*601T>A 3_prime_UTR_variant Exon 46 of 46 ENST00000262304.9 NP_001009944.3
TSC2NM_000548.5 linkc.*516A>T 3_prime_UTR_variant Exon 42 of 42 ENST00000219476.9 NP_000539.2 P49815-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PKD1ENST00000262304.9 linkc.*601T>A 3_prime_UTR_variant Exon 46 of 46 1 NM_001009944.3 ENSP00000262304.4 P98161-1
TSC2ENST00000219476.9 linkc.*516A>T 3_prime_UTR_variant Exon 42 of 42 5 NM_000548.5 ENSP00000219476.3 P49815-1

Frequencies

GnomAD3 genomes
AF:
0.290
AC:
44125
AN:
152020
Hom.:
9199
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.587
Gnomad AMI
AF:
0.134
Gnomad AMR
AF:
0.207
Gnomad ASJ
AF:
0.252
Gnomad EAS
AF:
0.00135
Gnomad SAS
AF:
0.0937
Gnomad FIN
AF:
0.232
Gnomad MID
AF:
0.272
Gnomad NFE
AF:
0.179
Gnomad OTH
AF:
0.258
GnomAD4 exome
AF:
0.153
AC:
2665
AN:
17420
Hom.:
262
Cov.:
0
AF XY:
0.154
AC XY:
1374
AN XY:
8926
show subpopulations
African (AFR)
AF:
0.513
AC:
154
AN:
300
American (AMR)
AF:
0.150
AC:
375
AN:
2506
Ashkenazi Jewish (ASJ)
AF:
0.202
AC:
70
AN:
346
East Asian (EAS)
AF:
0.00
AC:
0
AN:
1060
South Asian (SAS)
AF:
0.0917
AC:
148
AN:
1614
European-Finnish (FIN)
AF:
0.180
AC:
64
AN:
356
Middle Eastern (MID)
AF:
0.262
AC:
11
AN:
42
European-Non Finnish (NFE)
AF:
0.162
AC:
1688
AN:
10402
Other (OTH)
AF:
0.195
AC:
155
AN:
794
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
105
210
315
420
525
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.291
AC:
44213
AN:
152138
Hom.:
9233
Cov.:
34
AF XY:
0.287
AC XY:
21332
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.587
AC:
24361
AN:
41482
American (AMR)
AF:
0.207
AC:
3167
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.252
AC:
873
AN:
3468
East Asian (EAS)
AF:
0.00135
AC:
7
AN:
5176
South Asian (SAS)
AF:
0.0934
AC:
451
AN:
4830
European-Finnish (FIN)
AF:
0.232
AC:
2454
AN:
10596
Middle Eastern (MID)
AF:
0.276
AC:
81
AN:
294
European-Non Finnish (NFE)
AF:
0.179
AC:
12158
AN:
67968
Other (OTH)
AF:
0.255
AC:
539
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1328
2655
3983
5310
6638
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
392
784
1176
1568
1960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.239
Hom.:
844
Bravo
AF:
0.303
Asia WGS
AF:
0.0840
AC:
293
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Autosomal dominant polycystic kidney disease Benign:1
Feb 19, 2016
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
5.3
DANN
Benign
0.56
PhyloP100
0.054
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3087631; hg19: chr16-2139127; COSMIC: COSV51913315; COSMIC: COSV51913315; API